The SARS-CoV-2 infection causes inflammasome activation and pyroptosis in blood monocytes, and cleaved GSDMD was also detected in lung tissue sections and bronchoalveolar lavage fluid (BALF) patients with COVID-19 (Vora et al., 2021). This evidence concerns the gene GSDMD and COVID-19.